Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.

NCT06529562 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

384

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

RADIATION: Surgery combined with Target-reduction intensity-modulated radiotherapy
RADIATION: Surgery combined with Dose-reduction intensity-modulated radiotherapy

Sponsor

Ming-Yuan Chen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]